基于正念的住院团体心理治疗对青少年物质使用障碍的疗效:随机对照试验方案
本研究为前瞻性随机对照多中心试验,计划纳入340名13至19岁、正在接受住院或日间治疗且基线无急性精神病性或自杀症状的青少年物质使用障碍患者,比较在常规治疗基础上加用正念团体心理治疗(Mind it!)与常规治疗的附加疗效,主要结局为随访时过去30天物质使用,并探索正念、冲动性和情绪调节的中介作用。
要点
- 纳入13至19岁住院或日间治疗的青少年物质使用障碍患者,共340人。
- 干预组在常规治疗基础上加用正念团体心理治疗,对照组为常规治疗。
- 主要结局为随访时过去30天物质使用,采用时间线回溯自报评估。
核心结论
- 该试验旨在评估正念团体心理治疗对青少年物质使用障碍患者常规治疗的附加疗效,并探索干预可行性和治疗效应中介因素。
研究设计与样本
- 前瞻性随机对照多中心试验,计划纳入340名13至19岁正在接受儿童或青少年精神科或心理治疗住院或日间治疗的物质使用障碍患者。
- 纳入条件包括 detoxification 前30天报告有物质使用,且基线无急性精神病性或自杀症状。
- 评估时间点为完成前期脱毒阶段后(t0)、4周(t1)、8周(t2)及t2后6个月(t3)。
关键数值与推荐
- 主要结局为随访时基于时间线回溯自报的过去30天物质使用。
- 次要结局包括渴求、依赖严重程度和戒断动机。
- 正念、冲动性和情绪调节将作为可能的治疗效应中介因素进行分析。
临床怎么用
- 若试验证实附加疗效,正念团体心理治疗可作为青少年物质使用障碍住院或日间治疗中安全可行的附加治疗选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current treatments for adolescents with substance use disorder (SUD) have had only limited success. In recent years, research has underlined the role of self-regulatory processes and impulsivity in the development and maintenance of SUD in adolescents. Mindfulness has gained much attention due to its capacity to influence self-regulatory processes, particularly in adult populations. Initial studies have shown the potential of mindfulness-based approaches in younger SUD patients. The aim of the present clinical trial is to evaluate the added treatment effect of a mindfulness-based group psychotherapy ("Mind it!") for adolescents with SUD in comparison to the current standard treatment. Moreover, we seek to explore the feasibility of the intervention and possible mediators of treatment effects. METHODS/DESIGN: There will be N = 340 participants aged between 13 and 19 years who are receiving child or adolescent psychiatric or psychotherapeutic inpatient or day treatment targeting their SUD and who have reported substance use 30 days before detoxification and do not show acute psychotic or suicidal symptoms at baseline. The study is a prospective randomized controlled multi-center trial in which patients are assessed: (1) after completing a prior detoxification phase (t0), (2) at 4 weeks (t1), (3) at 8 weeks (t2), and (4) at 6 months after t2 (t3). Participants in the intervention group will receive mindfulness-based group psychotherapy in addition to their existing treatment regime. The primary outcome is substance use in the past 30 days at follow-up based on the Timeline Followback self-report. Secondary outcomes include craving, severity of dependence, and abstinence motivation. Mindfulness, impulsivity, and emotion regulation will be analyzed as possible mediators of treatment effects. DISCUSSION: This trial is expected to provide evidence of the added effect of a novel, safe, and feasible treatment option for adolescents with SUD. TRIAL REGISTRATION: German Register of Clinical Studies, DRKS00014041 . Registered on 17 April 2018.
引用
- Baldus C, Mokros L, Daubmann A, et al. Treatment effectiveness of a mindfulness-based inpatient group psychotherapy in adolescent substance use disorder - study protocol for a randomized controlled trial. Trials. 2018. PMID: 30587217. doi:10.1186/s13063-018-3048-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。